Related Experiment Video
Updated: Jun 18, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Bacterial meningitis: epidemiology, pathogenesis and management update.
Yuliya Nudelman1, Allan R Tunkel
1Department of Medicine, Monmouth Medical Center, Long Branch, New Jersey 07740, USA.
Drugs
|December 1, 2009
Summary
Bacterial meningitis is a serious global threat. Conjugate vaccines have shifted its epidemiology to adults, requiring timely diagnosis, cerebrospinal fluid analysis, and appropriate antimicrobial and dexamethasone therapies for better outcomes.
Area of Science:
- Infectious Diseases
- Neurology
- Public Health
Background:
- Bacterial meningitis remains a critical global health concern, posing a life-threatening emergency if not promptly diagnosed and managed.
- Epidemiology has shifted due to conjugate vaccines, making bacterial meningitis predominantly an adult disease in vaccinated populations.
- Current management involves urgent cerebrospinal fluid analysis and tailored antimicrobial and adjunctive therapies.
Purpose of the Study:
- To review the current understanding of bacterial meningitis management.
- To highlight the role of antimicrobial and adjunctive therapies, including dexamethasone.
- To discuss the evolving epidemiology and treatment strategies for bacterial meningitis.
Main Methods:
- Review of current literature on bacterial meningitis diagnosis and management.
- Analysis of epidemiological shifts following conjugate vaccine introduction.
- Evaluation of clinical evidence for antimicrobial and adjunctive dexamethasone therapy.
Main Results:
- Conjugate vaccines have altered the epidemiology, increasing the relative burden of bacterial meningitis in adults.
- Adjunctive dexamethasone therapy has proven beneficial in specific cases, such as *Haemophilus influenzae* type B meningitis in children and pneumococcal meningitis in adults, reducing mortality and adverse outcomes.
- The optimal use of dexamethasone in other bacterial meningitis contexts remains controversial, but timing with initial antimicrobial administration is crucial for efficacy.
Conclusions:
- Prompt diagnosis and management are essential for combating bacterial meningitis.
- Vaccination strategies have significantly impacted disease epidemiology.
- Judicious use of antimicrobial and adjunctive dexamethasone therapies, particularly concerning timing, is key to improving patient outcomes in bacterial meningitis.
Related Concept Videos
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:26Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...